MaxCyte, Inc. (MXCT)
USD 2.47
(-5.19%)
USD 2.47
(-5.19%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -27.76 Million USD | -651.93% |
| 2022 | 5.03 Million USD | 111.95% |
| 2021 | -42.1 Million USD | -257.12% |
| 2020 | -11.78 Million USD | -47.37% |
| 2019 | -7.99 Million USD | -29.2% |
| 2018 | -6.19 Million USD | 69.52% |
| 2017 | -20.31 Million USD | -202.23% |
| 2016 | -6.72 Million USD | -355.35% |
| 2015 | 2.63 Million USD | 62.09% |
| 2014 | 1.62 Million USD | 47.97% |
| 2013 | 1.09 Million USD | 163.14% |
| 2012 | 417 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -18.98 Million USD | -426.05% |
| 2024 Q1 | -3.6 Million USD | 87.0% |
| 2023 Q2 | -38.35 Million USD | -77.7% |
| 2023 Q4 | -27.76 Million USD | 16.09% |
| 2023 FY | -27.76 Million USD | -651.93% |
| 2023 Q3 | -33.08 Million USD | 13.72% |
| 2023 Q1 | -21.58 Million USD | -529.03% |
| 2022 Q3 | -27.99 Million USD | 70.43% |
| 2022 Q4 | 5.03 Million USD | 117.97% |
| 2022 Q1 | -226.52 Million USD | -438.06% |
| 2022 Q2 | -94.67 Million USD | 58.21% |
| 2022 FY | 5.03 Million USD | 111.95% |
| 2021 Q4 | -42.1 Million USD | 27.29% |
| 2021 Q2 | -36.2 Million USD | 52.95% |
| 2021 Q1 | -76.93 Million USD | -552.59% |
| 2021 Q3 | -57.9 Million USD | -59.95% |
| 2021 FY | -42.1 Million USD | -257.12% |
| 2020 Q4 | -11.78 Million USD | 0.0% |
| 2020 FY | -11.78 Million USD | -47.37% |
| 2020 Q1 | 16.7 Million USD | 308.87% |
| 2020 Q2 | -31.19 Million USD | -286.72% |
| 2019 Q1 | -11.46 Million USD | -85.22% |
| 2019 Q4 | -7.99 Million USD | 5.98% |
| 2019 Q3 | -8.5 Million USD | 25.81% |
| 2019 FY | -7.99 Million USD | -29.2% |
| 2019 Q2 | -11.46 Million USD | 0.0% |
| 2018 Q1 | -10.97 Million USD | 45.96% |
| 2018 Q2 | -10.97 Million USD | 0.0% |
| 2018 FY | -6.19 Million USD | 69.52% |
| 2018 Q3 | -6.19 Million USD | 43.59% |
| 2018 Q4 | -6.19 Million USD | 0.0% |
| 2017 Q1 | -25.15 Million USD | -274.31% |
| 2017 FY | -20.31 Million USD | -202.23% |
| 2017 Q4 | -20.31 Million USD | 0.02% |
| 2017 Q3 | -20.31 Million USD | 19.21% |
| 2017 Q2 | -25.14 Million USD | 0.04% |
| 2016 Q1 | -7.19 Million USD | -373.57% |
| 2016 Q4 | -6.72 Million USD | 0.21% |
| 2016 FY | -6.72 Million USD | -355.35% |
| 2016 Q3 | -6.73 Million USD | 6.29% |
| 2016 Q2 | -7.18 Million USD | 0.19% |
| 2015 Q3 | 2.61 Million USD | 128.6% |
| 2015 Q1 | 2.09 Million USD | 29.26% |
| 2015 FY | 2.63 Million USD | 62.09% |
| 2015 Q4 | 2.63 Million USD | 0.63% |
| 2015 Q2 | -9.14 Million USD | -535.69% |
| 2014 Q1 | 764.9 Thousand USD | 0.0% |
| 2014 Q4 | 1.62 Million USD | 9.83% |
| 2014 Q3 | 1.47 Million USD | 0.0% |
| 2014 FY | 1.62 Million USD | 47.97% |
| 2013 FY | 1.09 Million USD | 163.14% |
| 2012 FY | 417 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 202.515% |
| BrainsWay Ltd. | -10.32 Million USD | -169.021% |
| Cerus Corporation | 84.35 Million USD | 132.913% |
| Envoy Medical, Inc. | -3.81 Million USD | -627.923% |
| electroCore, Inc. | -9.95 Million USD | -178.885% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | -441.717% |
| IceCure Medical Ltd | -9.93 Million USD | -179.475% |
| Inogen, Inc. | -103.56 Million USD | 73.194% |
| OrthoPediatrics Corp. | -9.26 Million USD | -199.59% |
| Lucid Diagnostics Inc. | -3.64 Million USD | -662.51% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | -111.979% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | -440.337% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -4721.916% |
| Orthofix Medical Inc. | 96.44 Million USD | 128.787% |
| PAVmed Inc | 29.08 Million USD | 195.451% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | -63.9% |
| RxSight, Inc. | -6.68 Million USD | -315.614% |
| Sight Sciences, Inc. | -102.71 Million USD | 72.971% |
| SI-BONE, Inc. | 5.72 Million USD | 585.282% |
| TELA Bio, Inc. | -3.94 Million USD | -603.039% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 148.434% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | 7987.216% |
| Acutus Medical, Inc. | 12.27 Million USD | 326.101% |
| Talis Biomedical Corporation | -57.06 Million USD | 51.348% |
| Spectral AI, Inc. | -3.5 Million USD | -693.002% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 42.193% |
| CVRx, Inc. | -59.95 Million USD | 53.694% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | 1499.242% |
| PetVivo Holdings, Inc. | 1.27 Million USD | 2272.996% |
| Bioventus Inc. | 372.51 Million USD | 107.453% |
| Venus Concept Inc. | 74.3 Million USD | 137.366% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | -172.667% |
| LivaNova PLC | 62.53 Million USD | 144.398% |
| 908 Devices Inc. | -115.09 Million USD | 75.878% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 108.657% |
| Nemaura Medical Inc. | 9.92 Million USD | 379.728% |
| NeuroPace, Inc. | 54.33 Million USD | 151.094% |
| LENSAR, Inc. | -18.31 Million USD | -51.611% |
| Apyx Medical Corporation | -5.15 Million USD | -438.983% |
| Cutera, Inc. | 288.3 Million USD | 109.63% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | 469.434% |
| BioSig Technologies, Inc. | 262 Thousand USD | 10696.565% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 36.658% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | -201.805% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 101.976% |
| Axonics, Inc. | -77.19 Million USD | 64.035% |
| Outset Medical, Inc. | 67.67 Million USD | 141.022% |
| IRIDEX Corporation | -4.28 Million USD | -547.458% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 84.404% |
| IRadimed Corporation | -47.71 Million USD | 41.82% |
| Tivic Health Systems, Inc. | -3.02 Million USD | -817.482% |
| INVO Bioscience, Inc. | 8.45 Million USD | 428.512% |
| Telesis Bio, Inc. | 32.63 Million USD | 185.071% |
| Viemed Healthcare, Inc. | -2.5 Million USD | -1009.574% |
| Varex Imaging Corporation | 316.9 Million USD | 108.761% |
| Quipt Home Medical Corp. | 81.73 Million USD | 133.967% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -897.951% |
| Pulmonx Corporation | -42.36 Million USD | 34.459% |
| Dynatronics Corporation | 6.2 Million USD | 547.499% |
| Modular Medical, Inc. | -8.04 Million USD | -245.225% |
| ReShape Lifesciences Inc. | -4.29 Million USD | -546.102% |
| Semler Scientific, Inc. | -57.13 Million USD | 51.404% |
| InMode Ltd. | -135.39 Million USD | 79.495% |
| Bruker Corporation | 891.3 Million USD | 103.115% |
| Cytosorbents Corporation | 4.18 Million USD | 763.867% |
| DexCom, Inc. | 2.02 Billion USD | 101.369% |
| Align Technology, Inc. | -840.47 Million USD | 96.697% |
| Viveve Medical, Inc. | -13.81 Million USD | -100.992% |
| ZimVie Inc. | 450.41 Million USD | 106.164% |
| Movano Inc. | -5.86 Million USD | -373.287% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 79.352% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -4721.916% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | 1499.242% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 107.781% |
| Profound Medical Corp. | -18.17 Million USD | -52.724% |
| Insulet Corporation | 798.1 Million USD | 103.479% |
| enVVeno Medical Corporation | -2.21 Million USD | -1151.713% |
| Surmodics, Inc. | -12.01 Million USD | -131.089% |
| iCAD, Inc. | -21.2 Million USD | -30.902% |
| Nuwellis, Inc. | -2.81 Million USD | -884.853% |
| Biotricity, Inc. | 23.09 Million USD | 220.224% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 129.645% |
| Aethlon Medical, Inc. | -4.5 Million USD | -516.728% |
| InspireMD, Inc. | -8.04 Million USD | -245.096% |
| PAVmed Inc. | 29.08 Million USD | 195.451% |
| BIOLASE, Inc. | 11.34 Million USD | 344.737% |
| Beyond Air, Inc. | 6.22 Million USD | 545.706% |
| FONAR Corporation | -14.66 Million USD | -89.311% |
| AxoGen, Inc. | 32.26 Million USD | 186.044% |
| Vivani Medical, Inc. | 42 Thousand USD | 66202.381% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | -160.49% |
| Inari Medical, Inc. | -7.16 Million USD | -287.697% |
| UFP Technologies, Inc. | 40.77 Million USD | 168.09% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | 1004.738% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | -481.874% |
| Tenon Medical, Inc. | -1.25 Million USD | -2112.191% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | -265.014% |
| Co-Diagnostics, Inc. | -11.92 Million USD | -132.788% |
| AdaptHealth Corp. | 2.21 Billion USD | 101.252% |
| Sintx Technologies, Inc. | 905 Thousand USD | 3167.735% |
| NanoVibronix, Inc. | -3.27 Million USD | -746.949% |
| Quanterix Corporation | -132.95 Million USD | 79.119% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -897.951% |
| Sensus Healthcare, Inc. | -22.36 Million USD | -24.136% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 103.683% |
| TransMedics Group, Inc. | 121.13 Million USD | 122.919% |
| ReWalk Robotics Ltd. | -26.18 Million USD | -6.047% |
| NeuroMetrix, Inc. | -1.49 Million USD | -1761.951% |
| Hyperfine, Inc. | -75.61 Million USD | 63.286% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 118.242% |
| Biomerica, Inc. | -3.38 Million USD | -720.177% |
| Bone Biologics Corporation | -3.02 Million USD | -817.309% |
| AVITA Medical, Inc. | -26.23 Million USD | -5.838% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | -1410.163% |
| Silk Road Medical, Inc | 64.42 Million USD | 143.095% |